Exploring how metabolic control, obesity, and genetics impact lipid profiles in children with Type 1 Diabetes and their long-term cardiovascular health.
Discover how metformin, a common diabetes drug, lowers cholesterol through ChREBP-mediated PCSK9 regulation, revealing new connections between glucose and cholesterol metabolism.
Discover how diabetes and high cholesterol work together to damage kidney microvessels through the PACS2 protein at the MAM cellular interface.
Exploring the multifaceted roles of PCSK9 inhibition beyond cholesterol management, including inflammation, immunity, thrombosis, and potential cancer applications.
Discover how ANGPTL8, a newly discovered protein, is revolutionizing our understanding of cholesterol metabolism and heart health in non-diabetic individuals.